Long-term clinical outcome and risk stratification across stages of cardiovascular-kidney-metabolic syndrome in a nationwide cohort
A higher CKM stage was associated with a progressive increase in the risk of all-cause mortality and major cardiovascular events. Clinicians may benefit from prioritizing the early identification of high-risk individuals and implementing targeted management strategies based on CKM staging to improve long-term adverse outcomes.
Authors
- Hasung Kim (ORCID: https://orcid.org/0000-0002-2519-6244)
- Jeong‐Hun Shin (ORCID: https://orcid.org/0000-0002-6718-9763)
- Ha Hye Jo (ORCID: https://orcid.org/0009-0000-7123-0020)
- Jungkuk Lee (ORCID: https://orcid.org/0000-0003-1874-449X)
- Hyunjin Kim (ORCID: https://orcid.org/0000-0001-8336-881X)
- Byung Sik Kim
- Dong Wook Kim
- Ki‐Chul Sung
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Hanmi Pharmaceutical (South Korea) (KR)
- Kangbuk Samsung Hospital (KR)
- Hanyang University Guri Hospital (KR)
- Hanyang University Seoul Hospital (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- The Korean Journal of Internal Medicine
- Published
- 2025-10-28
- DOI
- https://doi.org/10.3904/kjim.2025.194
- Citations
- 2
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 2.86
Funders
- Hanyang University
- Ministry of Trade, Industry and Energy
- National Health Insurance Service